S&P 500, NASDAQ FUTURES NEAR RECORD HIGH WITH SENTIMENT BUOYANT

A tech-fuelled rally has led Wall Street to revise its year-ahead targets for the S&P 500

IMVT Jan 2026 30.000 put

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

8.80

0.00

(0.00%)

As of 02:50PM EDT. Market open.

Loading interactive chart...

Thomson Reuters StreetEvents
Q4 2024 Roivant Sciences Ltd Earnings Call
Q4 2024 Roivant Sciences Ltd Earnings Call
Investor's Business Daily
After Biohaven Kerfuffle, Immunovant Dives On A Surprise Delay
Immunovant stock slumped Thursday — reversing a day-earlier jump — after pivoting its focus to what one analyst called "a backup compound."
Zacks
Immunovant (IMVT) Falls as Q4 Earnings Miss, Pipeline in Focus
Immunovant (IMVT) declines 5% on dismal fourth-quarter fiscal 2024 results. The company names IMVT-1402 as its new lead candidate to initiate several studies for autoimmune indications.